Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Strong Buy

Price to Earnings Rating

Neutral

Analyst Rating

Neutral

Gritstone bio, Inc. Common Stock (GRTS)

Biological Products, (no Disgnostic Substances)

https://gritstonebio.com

Gritstone Bio Inc is a biotechnology company. The company is engaged in developing personalized cancer immunotherapies to fight multiple cancer types and infectious diseases. It is building a pipeline of Immunotherapies product candidates for patients with solid tumors, which includes GRANITE, SLATE, BiSAb, among others.

5959 HORTON STREET, SUITE 300
EMERYVILLE, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

09/28/2018

Market Cap

64,026,889

Shares Outstanding

95,340,000

Weighted SO

95,342,055

Total Employees

N/A

Upcoming Earnings

N/A

Beta

0.5040

Last Div

0.0000

Range

0.45-3.33

Chg

0.0120

Avg Vol

1478945

Mkt Cap

64026889

Exch

NASDAQ

Country

US

Phone

510 871 6100

DCF Diff

1.1951

DCF

-0.5940

Div Yield

0.0000

P/S

37.6629

EV Multiple

-0.7935

P/FV

3.5009

Div Yield %

0.0000

P/E

-0.5839

PEG

-0.1810

Payout

-0.0056

Current Ratio

2.5401

Quick Ratio

2.5401

Cash Ratio

2.1829

DSO

41.8676

DIO

0.0000

Op Cycle

41.8676

DPO

208.6868

CCC

-166.8192

Gross Margin

-3.2512

Op Margin

-87.8676

Pretax Margin

-78.2547

Net Margin

-78.2547

Eff Tax Rate

-0.0055

ROA

-0.9333

ROE

-3.2851

ROCE

-1.2591

NI/EBT

1.0000

EBT/EBIT

0.8906

EBIT/Rev

-87.8676

Debt Ratio

0.3344

D/E

2.1481

LT Debt/Cap

0.6461

Total Debt/Cap

0.6824

Int Coverage

-682.0776

CF/Debt

-2.6401

Equity Multi

6.4240

Rec Turnover

8.7179

Pay Turnover

1.7490

Inv Turnover

0.0000

FA Turnover

0.0222

Asset Turnover

0.0119

OCF/Share

-0.8782

FCF/Share

-0.8884

Cash/Share

0.3977

OCF/Sales

-74.0235

FCF/OCF

1.0116

CF Coverage

-2.6401

ST Coverage

-17.5779

CapEx Coverage

-86.2509

Div&CapEx Cov

-57.1740

P/BV

3.5009

P/B

3.5009

P/S

37.6629

P/E

-0.5839

P/FCF

-0.5030

P/OCF

-0.6173

P/CF

-0.6173

PEG

-0.1810

P/S

37.6629

EV Multiple

-0.7935

P/FV

3.5009

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Aug 08, 01:00 GRITSTONE ALERT: Bragar Eagel & Squire, P.C. is Investigating Gritstone bio, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm GlobeNewswire Inc. Aug 04, 20:34 GRTS DEADLINE NOTICE: ROSEN, A LEADING LAW FIRM, Encourages Gritstone bio, Inc. Investors to Secure Counsel Before Important August 6 Deadline in Securities Class Action – GRTS GlobeNewswire Inc. Aug 03, 01:00 Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Scotts, Gritstone, Fat Brands, and Charge and Encourages Investors to Contact the Firm GlobeNewswire Inc. Jul 25, 21:56 ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Gritstone bio, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – GRTS GlobeNewswire Inc. Jan 10, 16:30 Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) MarketWatch Jan 06, 05:58 The Russell 2000 Index has soared, but you might be better off looking elsewhere for quality small-cap stocks MarketWatch Jan 02, 12:26 The Russell 2000 Index has soared, but you might be better off looking elsewhere for quality small-cap stocks MarketWatch Jan 02, 12:26 The Russell 2000 Index has soared, but you might be better off looking elsewhere for quality small-cap stocks GlobeNewswire Inc. Dec 07, 16:30 Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire Inc. Nov 07, 16:30 Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Revenue Product Segmentation